These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8168751)

  • 1. [CA-125: a serum tumor marker in ovarian cancer].
    Cohen AD; Piura B; Cohen Y
    Harefuah; 1994 Feb; 126(3):154-9. PubMed ID: 8168751
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tumor marker CA 72-4 in ovarian cancer in comparison with CA 125 and D-dimer].
    Schelling M; Jänicke F; Senekowitsch R; Lörken A
    Gynakol Rundsch; 1991; 31 Suppl 2():286-9. PubMed ID: 1665138
    [No Abstract]   [Full Text] [Related]  

  • 3. [CA 125 in diagnosis and prognosis of epithelial ovarian cancer].
    Cohen AD; Piura B; Cohen Y; Shoenfeld Y
    Harefuah; 1994 Mar; 126(5):283-5, 303. PubMed ID: 8188111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The CA-125 tumor marker in epithelial ovarian cancers of stage I].
    Nagele F; Vavra N; Kurz C; Sevelda P
    Wien Klin Wochenschr; 1993; 105(20):585-8. PubMed ID: 8259686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of a cancer antigen CA 125 associated with ovarian cancer. (IV) Serum CA 125 levels through normal menstrual cycle and in benign diseases].
    Suzuki M; Sekiguchi I; Ohwada M; Tamada T; Sakurabayashi I; Kawai T
    Rinsho Byori; 1985 Mar; 33(3):285-8. PubMed ID: 3859676
    [No Abstract]   [Full Text] [Related]  

  • 6. [Detection of CA 125 in the serum and tissue of patients with ovarian neoplasms].
    Kristen P; Beier HJ; Kaesemann H; Caffier H
    Gynakol Rundsch; 1989; 29 Suppl 2():358-60. PubMed ID: 2693257
    [No Abstract]   [Full Text] [Related]  

  • 7. Unique case of massive ascites, extreme elevation of serum CA 125 tumour marker.
    Jotkowitz MW; Gee DC
    Aust N Z J Obstet Gynaecol; 1993 Nov; 33(4):453-4. PubMed ID: 8179576
    [No Abstract]   [Full Text] [Related]  

  • 8. CA 125 as a marker in epithelial ovarian cancer: Alone and in comparison with CEA.
    Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH; Balar DB; Patel TB
    Indian J Cancer; 1987 Dec; 24(4):222-31. PubMed ID: 3505511
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor associated trypsin inhibitor and CA-125 during treatment of mucinous ovarian cancer in 2 patients.
    Mogensen O
    Eur J Cancer; 1991; 27(9):1180-1. PubMed ID: 1659852
    [No Abstract]   [Full Text] [Related]  

  • 10. A proposal to use CA-125 to evaluate activity of new antineoplastic agents in ovarian cancer.
    Markman M
    Gynecol Oncol; 1993 Dec; 51(3):297-8. PubMed ID: 8112634
    [No Abstract]   [Full Text] [Related]  

  • 11. Significance of some tumor markers in differential diagnosis of ovarian tumor.
    Zakrzewska I; Borawska R; Poznański J; Maćkowiak B
    Rocz Akad Med Bialymst; 1999; 44():235-43. PubMed ID: 10697438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage colony-stimulating factor as a tumor marker for epithelial ovarian cancer.
    Suzuki M; Ohwada M; Aida I; Tamada T; Hanamura T; Nagatomo M
    Obstet Gynecol; 1993 Dec; 82(6):946-50. PubMed ID: 8233270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concentration of Ca 125 in pregnant women after spontaneous or postmenopausal gonadotrophin-induced ovulation].
    Baviera G; Purello D'Ambrosio F
    Riv Eur Sci Med Farmacol; 1989 Feb; 11(1):55-8. PubMed ID: 2798992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of markers may prove useful in screening for ovarian CA.
    Oncology (Williston Park); 1994 Jun; 8(6):79-80. PubMed ID: 8074986
    [No Abstract]   [Full Text] [Related]  

  • 15. Resetting the CA-125 range for a complete response to chemotherapy: why?
    Markman M
    Gynecol Oncol; 1994 Jun; 53(3):281-2. PubMed ID: 8206398
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between saliva and serum CA 125 in women with and without epithelial ovarian cancer.
    Plante M; Wong GY; Nisselbaum JS; Almadrones L; Hoskins WJ; Rubin SC
    Obstet Gynecol; 1993 Jun; 81(6):989-92. PubMed ID: 8497368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyst fluid CA 125 levels in ovarian epithelial neoplasms.
    Menczer J; Ben-Baruch G; Moran O; Lipitz S
    Obstet Gynecol; 1993 Jan; 81(1):25-8. PubMed ID: 8416456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biomarker in gynecologic malignancies].
    Isonishi S
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1003-7. PubMed ID: 15272576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring CA 125 serum levels during early chemotherapy is an excellent prognostic method in advanced ovarian cancer.
    Högberg T; Kågedal B
    Gynecol Oncol; 1993 Mar; 48(3):413-4. PubMed ID: 8462909
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers].
    Nozawa S; Udagawa Y; Ito K; Susumu N; Sasaki H; Aoki D
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):279-85. PubMed ID: 8434967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.